The Hematology/Oncology Pharmacy Association Oral Chemotherapy Collaborative (HOPA OCC), with the participation of ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs).
The tools include a baseline OAA program assessment, a clinical OAA adherence tool offering questions and guidance, and an OAA dashboard featuring metrics for measuring program outcomes. During the development and research process, implementation barriers were identified as well - including deficits in information technology, resources, and competing priorities.
The tools, resources, and results have been published in JCO Oncology Practice.
Authors: Victoria Nachar, PharmD, BCOP; Marjorie Adams Curry, PharmD, BCOP; Diana Kostoff, PharmD, BCPS, BCOP; Angela Wood, PharmD, BCOP; Karen B. Farris, PhD; Benyam Muluneh, PharmD, BCOP; Amy Morris, PharmD, BCOP; Michael Keng, MD; Vedner Guerrier, MBA, LSSBB; and Emily R. Mackler, PharmD, BCOP
